199 related articles for article (PubMed ID: 36769158)
21. Protein and mRNA levels of YKL-40 in high-grade glioma.
Kazakova MH; Staneva DN; Koev IG; Staikov DG; Mateva N; Timonov PT; Miloshev GA; Sarafian VS
Folia Biol (Praha); 2014; 60(6):261-7. PubMed ID: 25629266
[TBL] [Abstract][Full Text] [Related]
22. Transcriptome profiling reveals PDZ binding kinase as a novel biomarker in peritumoral brain zone of glioblastoma.
Kruthika BS; Jain R; Arivazhagan A; Bharath RD; Yasha TC; Kondaiah P; Santosh V
J Neurooncol; 2019 Jan; 141(2):315-325. PubMed ID: 30460633
[TBL] [Abstract][Full Text] [Related]
23. RNF135, RING finger protein, promotes the proliferation of human glioblastoma cells in vivo and in vitro via the ERK pathway.
Liu Y; Wang F; Liu Y; Yao Y; Lv X; Dong B; Li J; Ren S; Yao Y; Xu Y
Sci Rep; 2016 Feb; 6():20642. PubMed ID: 26856755
[TBL] [Abstract][Full Text] [Related]
24. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
25. Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts.
Leiss L; Mutlu E; Øyan A; Yan T; Tsinkalovsky O; Sleire L; Petersen K; Rahman MA; Johannessen M; Mitra SS; Jacobsen HK; Talasila KM; Miletic H; Jonassen I; Li X; Brons NH; Kalland KH; Wang J; Enger PØ
BMC Cancer; 2017 Feb; 17(1):108. PubMed ID: 28173797
[TBL] [Abstract][Full Text] [Related]
26. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
[TBL] [Abstract][Full Text] [Related]
27. Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas.
Büschges R; Weber RG; Actor B; Lichter P; Collins VP; Reifenberger G
Brain Pathol; 1999 Jul; 9(3):435-42; discussion 432-3. PubMed ID: 10416984
[TBL] [Abstract][Full Text] [Related]
28. Difference in Immunosuppressive Cells Between Peritumoral Area and Tumor Core in Glioblastoma.
Tamura R; Ohara K; Sasaki H; Morimoto Y; Kosugi K; Yoshida K; Toda M
World Neurosurg; 2018 Dec; 120():e601-e610. PubMed ID: 30165233
[TBL] [Abstract][Full Text] [Related]
29. Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.
Prasanna P; Patel J; Partovi S; Madabhushi A; Tiwari P
Eur Radiol; 2017 Oct; 27(10):4188-4197. PubMed ID: 27778090
[TBL] [Abstract][Full Text] [Related]
30. MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens.
Tovi M; Hartman M; Lilja A; Ericsson A
Acta Radiol; 1994 Sep; 35(5):495-505. PubMed ID: 8086262
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value and immune cell infiltration of hypoxic phenotype-related gene signatures in glioblastoma microenvironment.
Xiao K; Tan J; Yuan J; Peng G; Long W; Su J; Xiao Y; Xiao Q; Wu C; Qin C; Hu L; Liu K; Liu S; Zhou H; Ning Y; Ding X; Liu Q
J Cell Mol Med; 2020 Nov; 24(22):13235-13247. PubMed ID: 33009892
[TBL] [Abstract][Full Text] [Related]
32. Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties.
Clavreul A; Guette C; Faguer R; Tétaud C; Boissard A; Lemaire L; Rousseau A; Avril T; Henry C; Coqueret O; Menei P
J Pathol; 2014 May; 233(1):74-88. PubMed ID: 24481573
[TBL] [Abstract][Full Text] [Related]
33. Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme.
Lam PY; Di Tomaso E; Ng HK; Pang JC; Roussel MF; Hjelm NM
Br J Neurosurg; 2000 Feb; 14(1):28-32. PubMed ID: 10884881
[TBL] [Abstract][Full Text] [Related]
34. Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T cells in patients with malignant glioma reveals differential expression of the immunologic transcriptome compared with T cells from healthy volunteers.
Learn CA; Fecci PE; Schmittling RJ; Xie W; Karikari I; Mitchell DA; Archer GE; Wei Z; Dressman H; Sampson JH
Clin Cancer Res; 2006 Dec; 12(24):7306-15. PubMed ID: 17189402
[TBL] [Abstract][Full Text] [Related]
35. A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial Changes.
Dusart P; Hallström BM; Renné T; Odeberg J; Uhlén M; Butler LM
Cell Rep; 2019 Nov; 29(6):1690-1706.e4. PubMed ID: 31693905
[TBL] [Abstract][Full Text] [Related]
36. Proteomic analysis of glioblastomas: what is the best brain control sample?
Lemée JM; Com E; Clavreul A; Avril T; Quillien V; de Tayrac M; Pineau C; Menei P
J Proteomics; 2013 Jun; 85():165-73. PubMed ID: 23651564
[TBL] [Abstract][Full Text] [Related]
37. A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations.
Ho KT; Chen PF; Chuang JY; Gean PW; Hsueh YS
Life Sci; 2022 Jan; 288():120176. PubMed ID: 34848192
[TBL] [Abstract][Full Text] [Related]
38. Prediction of a competing endogenous RNA co-expression network as a prognostic marker in glioblastoma.
Peng Q; Li R; Li Y; Xu X; Ni W; Lin H; Ning L
J Cell Mol Med; 2020 Nov; 24(22):13346-13355. PubMed ID: 33047898
[TBL] [Abstract][Full Text] [Related]
39. The application and prospect of CDK4/6 inhibitors in malignant solid tumors.
Du Q; Guo X; Wang M; Li Y; Sun X; Li Q
J Hematol Oncol; 2020 May; 13(1):41. PubMed ID: 32357912
[TBL] [Abstract][Full Text] [Related]
40. Palbociclib Effectively Halts Proliferation but Fails to Induce Senescence in Patient-Derived Glioma Stem Cells.
Morris-Hanon O; Marazita MC; Romorini L; Isaja L; Fernandez-Espinosa DD; Sevlever GE; Scassa ME; Videla-Richardson GA
Mol Neurobiol; 2019 Nov; 56(11):7810-7821. PubMed ID: 31124078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
